NEW YORK (GenomeWeb) – Following Invitae's announcement earlier this week that its first quarter revenues rose sharply year over year, investment bank Leerink today upgraded shares of the company to an Outperform rating. 

Analyst Dan Leonard upgraded the San Francisco-based molecular diagnostics firm from a prior Market Perform rating but kept the price target on its shares at $20.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.